Covid Booster Costs Spur Calls to Shift From Free Jabs for All

April 11, 2022 |
Congressional delays could undermine COVID-19 global fight
Pfizer faces criticism for arguing that intellectual property for its Covid-19 pill is a human right
Related Posts
Access to Medicines

Congress’s Spending Bill...
Health Justice

PEPFAR can’t kee...
Funding the Fight

We’re turning up the hea...